Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$512M |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$458M |
| 3 |
Toronto Dominion Bank
TD
|
+$275M |
| 4 |
Shopify
SHOP
|
+$265M |
| 5 |
TC Energy
TRP
|
+$244M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$363M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$202M |
| 3 |
Restaurant Brands International
QSR
|
+$198M |
| 4 |
Canadian Natural Resources
CNQ
|
+$121M |
| 5 |
Invitation Homes
INVH
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.93% |
| 2 | Technology | 14.17% |
| 3 | Miscellaneous | 12.5% |
| 4 | Healthcare | 8.07% |
| 5 | Communication Services | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ARCH
3501
DELISTED
Arch Resources, Inc.
ARCH
| $42K | ﹤0.01% |
1,528
+1,439
| +1,617% | +$44.7K |
2019 Q2
4 quarters
|
|
3502
Central Garden & Pet Co
CENT
$2.45B
| $41K | ﹤0.01% |
1,426
+1,123
| +371% | +$30.2K |
2017 Q2
12 quarters
|
|
3503
iShares MSCI United Kingdom ETF
EWU
$3.56B
| $41K | ﹤0.01% |
1,585
| – | – |
2016 Q2
16 quarters
|
|
|
IGMS
3504
DELISTED
IGM Biosciences
IGMS
| $41K | ﹤0.01% |
+567
| New | +$34.4K |
2020 Q2
0 quarters
|
|
3505
Krystal Biotech
KRYS
$9.63B
| $41K | ﹤0.01% |
+959
| New | +$46.1K |
2020 Q2
0 quarters
|
|
|
HAPN
3506
Happen Inc
HAPN
$1.78B
| $41K | ﹤0.01% |
+8,502
| New | +$52.9K |
2020 Q2
0 quarters
|
|
3507
Lloyds Banking Group
LYG
$78B
| $41K | ﹤0.01% |
27,991
-29,577
| -51% | -$44.4K |
2013 Q2
28 quarters
|
|
3508
Pitney Bowes
PBI
$2.28B
| $41K | ﹤0.01% |
17,096
+10,110
| +145% | +$25.2K |
2013 Q2
28 quarters
|
|
|
PGRE
3509
DELISTED
Paramount Group
PGRE
| $41K | ﹤0.01% |
+5,907
| New | +$49.8K |
2020 Q2
0 quarters
|
|
3510
Invesco BuyBack Achievers ETF
PKW
$1.69B
| $41K | ﹤0.01% |
725
-319
| -31% | -$17.4K |
2013 Q2
28 quarters
|
|
3511
VSE Corp
VSEC
$4.51B
| $41K | ﹤0.01% |
1,500
+1,452
| +3,025% | +$33.1K |
2018 Q2
8 quarters
|
|
|
TPC
3512
Tutor Perini Cor
TPC
$4.38B
| $41K | ﹤0.01% |
3,716
+1,966
| +112% | +$17.6K |
2014 Q2
24 quarters
|
|
3513
PUT
Altimmune
ALT
$537M
| $40K | ﹤0.01% |
2,000
| – | – |
2020 Q1
1 quarter
|
|
3514
Barrett Business Services
BBSI
$759M
| $40K | ﹤0.01% |
3,156
+2,360
| +296% | +$27.3K |
2016 Q2
16 quarters
|
|
3515
Gran Tierra Energy
GTE
$354M
| $40K | ﹤0.01% |
11,685
+1,214
| +12% | +$3.93K |
2013 Q2
28 quarters
|
|
3516
Hyatt Hotels
H
$15.2B
| $40K | ﹤0.01% |
815
+347
| +74% | +$18.5K |
2013 Q2
28 quarters
|
|
3517
Immunovant
IMVT
$6.95B
| $40K | ﹤0.01% |
+1,528
| New | +$32.7K |
2020 Q2
0 quarters
|
|
|
KE
3518
Kimball Electronics
KE
$679M
| $40K | ﹤0.01% |
3,229
+1,707
| +112% | +$21.9K |
2015 Q1
21 quarters
|
|
3519
MannKind Corp
MNKD
$1.27B
| $40K | ﹤0.01% |
21,824
+17,024
| +355% | +$23.8K |
2019 Q2
4 quarters
|
|
3520
STMicroelectronics
STM
$47.7B
| $40K | ﹤0.01% |
1,434
-893
| -38% | -$22.2K |
2014 Q1
25 quarters
|
|
|
SYRS
3521
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $40K | ﹤0.01% |
+333
| New | +$29.9K |
2020 Q2
0 quarters
|
|
|
ODT
3522
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $40K | ﹤0.01% |
+1,047
| New | +$33.9K |
2020 Q2
0 quarters
|
|
|
LN
3523
DELISTED
LINE Corporation
LN
| $40K | ﹤0.01% |
779
-69
| -8% | -$3.41K |
2017 Q1
13 quarters
|
|
|
RST
3524
DELISTED
ROSETTA STONE INC
RST
| $40K | ﹤0.01% |
2,570
+1,877
| +271% | +$31.5K |
2015 Q4
18 quarters
|
|
3525
BGSF Inc
BGSF
$53.2M
| $39K | ﹤0.01% |
4,041
+1,641
| +68% | +$16.8K |
2018 Q2
8 quarters
|
|
Similar funds
Bank of Montreal's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of Montreal held 4,997 positions worth $110B, up 26% from $87.3B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Bank of Montreal's Q2 2020 filing shows 847 new, 2,326 increased, 1,132 reduced and 338 closed positions. Its largest new stake was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M. The largest sale was Amazon, an estimated $363M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Miscellaneous.
- Bank of Montreal's largest Q2 2020 buy was iShares AAA-A Rated Corporate Bond ETF: 781,910 shares worth $45.7M.
- Bank of Montreal added most to Mastercard in Q2 2020, an estimated $512M increase.
- Bank of Montreal's biggest Q2 2020 reduction was Amazon, cutting an estimated $363M.
- Bank of Montreal fully exited Allergan plc in Q2 2020, selling an estimated $94M.
- Bank of Montreal's ten largest holdings make up 22% of its $110B portfolio in Q2 2020.
- Bank of Montreal opened 847 new positions and closed 338 in Q2 2020.
- Bank of Montreal's portfolio value rose 26% quarter-over-quarter to $110B.
Based on Bank of Montreal's 13F filing for Q2 2020, filed 12 Aug 2020.